These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8396209)

  • 21. Hypertension in hypophosphatemic rickets--role of secondary hyperparathyroidism.
    Alon US; Monzavi R; Lilien M; Rasoulpour M; Geffner ME; Yadin O
    Pediatr Nephrol; 2003 Feb; 18(2):155-8. PubMed ID: 12579406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rickets guidance: part II-management.
    Haffner D; Leifheit-Nestler M; Grund A; Schnabel D
    Pediatr Nephrol; 2022 Oct; 37(10):2289-2302. PubMed ID: 35352187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG; Brown R; Baum M
    Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
    Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
    J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary hypophosphatemia in adults].
    Vélayoudom-Céphise FL; Vantyghem MC; Wémeau JL
    Presse Med; 2005 Dec; 34(22 Pt 1):1720-6. PubMed ID: 16374396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final height of Japanese patients with X-linked hypophosphatemic rickets: effect of vitamin D and phosphate therapy.
    Miyamoto J; Koto S; Hasegawa Y
    Endocr J; 2000 Apr; 47(2):163-7. PubMed ID: 10943740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia.
    Seikaly M; Browne R; Baum M
    Pediatrics; 1996 Jan; 97(1):91-3. PubMed ID: 8545232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical and molecular genetic study of hypophosphatemic rickets in children.
    Cho HY; Lee BH; Kang JH; Ha IS; Cheong HI; Choi Y
    Pediatr Res; 2005 Aug; 58(2):329-33. PubMed ID: 16055933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis.
    Reusz GS; Hoyer PF; Lucas M; Krohn HP; Ehrich JH; Brodehl J
    Arch Dis Child; 1990 Oct; 65(10):1125-8. PubMed ID: 2248503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching from conventional therapy to burosumab injection has the potential to prevent nephrocalcinosis in patients with X-linked hypophosphatemic rickets.
    Harada D; Ueyama K; Oriyama K; Ishiura Y; Kashiwagi H; Yamada H; Seino Y
    J Pediatr Endocrinol Metab; 2021 Jun; 34(6):791-798. PubMed ID: 33837680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutics of X-linked hypophosphatemic rickets.
    Latta K; Hisano S; Chan JC
    Pediatr Nephrol; 1993 Dec; 7(6):744-8. PubMed ID: 8130097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphate matters when investigating hypercalcemia: a mutation in SLC34A3 causing HHRH.
    Tang AR; Hinz LE; Khan A; Kline GA
    Endocrinol Diabetes Metab Case Rep; 2019 Jul; 2019(1):1-6. PubMed ID: 31352694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperparathyroidism in patients with X-linked dominant hypophosphatemic rickets--application of the calcium infusion test as an indicator for parathyroidectomy.
    Alon U; Newsome H; Chan JC
    Int J Pediatr Nephrol; 1984 Mar; 5(1):39-43. PubMed ID: 6609135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
    Lyles KW; Drezner MK
    J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia.
    Seikaly MG; Baum M
    Pediatrics; 2001 Jul; 108(1):E6. PubMed ID: 11433085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria.
    Chen C; Carpenter T; Steg N; Baron R; Anast C
    Pediatrics; 1989 Aug; 84(2):276-80. PubMed ID: 2787497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrocalcinosis.
    Alon US
    Curr Opin Pediatr; 1997 Apr; 9(2):160-5. PubMed ID: 9204244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.
    Nakajima S; Yamaoka K; Yamamoto T; Okada S; Tanaka H; Seino Y
    Bone Miner; 1990 Sep; 10(3):201-9. PubMed ID: 2171704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.
    Kooh SW; Binet A; Daneman A
    Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.